Adspread vs Free Ad Diagnosis Tool in 2026: managed Telegram buying vs free campaign triage

Adspread is a managed campaign workflow for Telegram. It starts with a buyer’s audience, geography, language, budget, and offer, then creates a plan the buyer approves before delivery. The three published routes are channel placements, official Telegram Ads, and Mini App campaigns. In the catalog route, a marketer can assess a channel’s topic, language, subscriber count, and average views before Adspread coordinates booking with the publisher. That service matters when the difficult part is getting approved placements organised, not operating another self-serve dashboard.

The official Telegram Ads route is operationally specific. Adspread runs the campaign in the Telegram Ads account it operates, so the advertiser does not need to operate its own account. It checks copy and destination, submits approved ads for moderation, manages CPM bids and variants, and reports during and after the campaign. The format is a Sponsored Message of up to 160 characters with a button in matched public channels. Its destination is the customer’s Telegram channel or working bot, not an external website. Channel posts have more flexible destinations, subject to agreement with the publisher.

No public rate card is published. Adspread says there are no packages or subscriptions: customers set a campaign budget, compare placements and prices after signing in, approve a confirmed plan, and reserve funds only after that approval. Charges occur after each placement is completed as agreed. The dashboard keeps the request, status, and budget visible, but the site does not publish an analytics API, export, or independently verified performance benchmark. It fits a deliberate Telegram buy with clear approval and measurement terms, not a team seeking automated diagnosis of an existing account.

Free Ad Diagnosis Tool is a browser questionnaire from NEO Digital Marketing for an advertiser who knows performance is off but has not isolated the first place to look. It begins with one of six reported problems: poor lead quality, high cost per lead, a performance drop, high CPC, enough leads but weak sales, or uncertainty about the problem. The subsequent questions adapt to that answer and to the chosen platform. This is useful triage because a Search campaign with intent and landing-page issues needs a different inspection path from a Meta lead campaign with creative, audience, or frequency concerns.

The Google Ads path can ask about campaign type, search-intent fit, spend, clicks, leads, CPC, Quality Score, location targeting, tracking, and the post-click next step. The Meta path can ask about creative format, objective, audience approach, spend, impressions, reach, clicks, leads, frequency, and lead capture. When inputs allow, the tool derives CPC, CPL, conversion rate, CTR, CPM, or frequency signals. Short-video and Reel users can enter three-second views and ThruPlays for directional hook and hold signals. The output shows a health score, confidence percentage, first focus, funnel stages, and up to four suggested actions.

The limit is deliberately clear: the diagnosis is based on answers entered in the browser. It does not require or publish a Google Ads or Meta account connection, scheduled monitoring, API, team workspace, integration, or client-reporting feature. It can compare a later result with the last diagnosis in browser local storage and offers Download or Print Report, but that is not ongoing account analytics. The tool is free to use and has no published paid tiers. Use it before changing budgets or targeting, then validate every suggested area against the account, analytics, conversion setup, and landing experience.